Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy
Recruiting
Phase 4
Interventional Study
Pancreatoduodenectomy
Pain Management
Opioid Analgesia
Multimodal Analgesia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 93 (estimated)
- Sponsor
- Iuliu Hatieganu University of Medicine and Pharmacy · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to determine whether continuous nefopam administration, as part of a multimodal analgesia strategy, reduces opioid consumption and improves patient satisfaction after pancreatoduodenectomy.
The main questions are:
Does nefopam administration reduce opioid consumption after pancreatoduodenectomy?
Does nefopam administration reduce postoperative pain levels afte…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients scheduled for elective pancreatoduodenectomy surgery
2. Agreed to participate in the study
Exclusion Criteria:
1. Refusal to participate
2. Emergency surgery
3. Patients with neurological disorders or other muscular or psychiatric disorders that impede communicatio…
Contacts